Why is Mangalam Drugs falling/rising?

As of 28-Oct, Mangalam Drugs and Organics Ltd is experiencing a decline in its stock price, currently at Rs. 64.35, which reflects a decrease of Rs. 3.35 or 4.95%. The stock has hit a new 52-week low of Rs. 63.63 today and has underperformed its sector by 4.69%. Over the past three days, the stock has consistently fallen, resulting in an overall decline of 8.1%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite this negative performance, there has been a notable increase in investor participation, with delivery volume rising by 197.63% compared to the 5-day average. In the broader market context, Mangalam Drugs has significantly underperformed compared to the Sensex, with a 1-week return of -4.13% against the benchmark's positive return of +0.24%. Over the past month, the stock has decreased by 10.71%, while the Sensex has gained 5.22%. Year-to-date, Mangalam Drugs has seen a staggering decline of 44.50%, contrasting sharply with the Sensex's increase of 8.30%. This stark difference highlights the challenges faced by Mangalam Drugs in the current market environment, contributing to its falling stock price.